VM Share Price | Voyageur Pharmaceuticals Ltd. Stock Analysis & Recommendation

Results Declared: Voyageur Pharmaceuticals Ltd. has declared results on 23 Apr 2026! Click here to unlock the latest financial performance

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Voyageur Pharmaceuticals Ltd. with Similar Stocks

Global Battery Metals Ltd.Grid Battery Metals, Inc.QMC Quantum Minerals Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Chemicals & Petrochemicals

Market cap

CAD 21 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.18

Return on Equity

-282.05%

Price to Book

17.11

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Feb 2026)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-28.57%

6 Months

-33.33%

1 Year

-42.86%

2 Years

100.0%

3 Years

25.0%

4 Years

0.0%

5 Years

-33.33%

Voyageur Pharmaceuticals Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

0.00%

EBIT Growth (5y)

0.00%

EBIT to Interest (avg)

-0.80

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.50

Sales to Capital Employed (avg)

0.01

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

18.57

EV to EBIT

-15.23

EV to EBITDA

-15.25

EV to Capital Employed

25.88

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-169.93%

ROE (Latest)

-121.86%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Feb'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Feb 2026 is 0.00% vs 0.00% in Feb 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Feb 2026 is 25.00% vs -166.67% in Feb 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Feb'26",
        "Feb'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.60",
          "val2": "-0.80",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "-0.80",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-32,552.80%",
          "val2": "0.00%",
          "chgp": "-3,255.28%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Nov'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Nov 2025 is 0.00% vs 0.00% in Nov 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Nov 2025 is -105.88% vs -21.43% in Nov 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.50",
          "val2": "-1.70",
          "chgp": "-105.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.50",
          "val2": "-1.70",
          "chgp": "-105.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-302,315.60%",
          "val2": "0.00%",
          "chgp": "-30,231.56%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Feb'26 - YoY

Feb'26

Feb'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.60

-0.80

25.00%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.60

-0.80

25.00%

Operating Profit Margin (Excl OI)

-32,552.80%

0.00%

-3,255.28%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Feb 2026 is 0.00% vs 0.00% in Feb 2025

Consolidated Net Profit

YoY Growth in quarter ended Feb 2026 is 25.00% vs -166.67% in Feb 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Nov'25

Nov'25

Nov'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-3.50

-1.70

-105.88%

Interest

0.00

Exceptional Items

0.00

-0.00

Consolidate Net Profit

-3.50

-1.70

-105.88%

Operating Profit Margin (Excl OI)

-302,315.60%

0.00%

-30,231.56%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Nov 2025 is 0.00% vs 0.00% in Nov 2024

Consolidated Net Profit

YoY Growth in year ended Nov 2025 is -105.88% vs -21.43% in Nov 2024

All Annual Results

Company CV

About Voyageur Pharmaceuticals Ltd.

Voyageur Pharmaceuticals Ltd.

Chemicals & Petrochemicals

Voyageur Pharmaceuticals Ltd., formerly Voyageur Minerals Ltd., is an exploration stage pharmaceutical company. The Company is focused on manufacturing mineral based pharmaceutical products. The Company is engaged in the acquisition, exploration and evaluation of pharmaceutical mineral resource properties. It has interests in five mineral properties located in the province of British Colombia, Canada and the state of Utah, United States of America.

Company Coordinates

Company Details

Suite 255, 339 50th Avenue SE , CALGARY AB : T2G 2B3

Tel: 1 587 7796166

https://voyageurpharmaceuticals.ca/

Registrar Details